NFKB1 and hepatocellular carcinoma: Inhibition of the nuclear translocation of NF-κB induced by TNF-α or LPS supports the anti-inflammatory properties of these compounds, considering that NF-κB is the signal pathway connecting the chronic inflammation and hepatocellular carcinoma.39